Application 218364
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No |
| 002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No |
| 003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218364-001 | AP |
| A218364-002 | AP |
| A218364-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | a05bbfa4-c34f-4134-8207-db79e4c70445 | 2026-06-12 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 23073db5-3fc4-4051-a22d-e49a63e42647 | 2026-06-10 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 94d042f7-93b9-43bd-9ace-cfc61903b4d7 | 2026-06-08 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 74ccc9f1-b957-4b1b-9464-1b5e3318c916 | 2026-06-08 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c4b2da6a-ed50-4a54-90bd-32f76b178736 | 2026-06-08 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 53843871-23e3-974e-e063-6394a90a8042 | 2026-06-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | f924d55d-d7ec-4448-b54e-3a7eaf5a1cab | 2026-06-04 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | c12d8af3-39a8-4690-8d47-43dec70b7579 | 2026-06-01 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Injecta Medcial LLC | 52fa0eec-3dd9-59ca-e063-6394a90a9791 | 2026-05-29 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals, Inc. | 419b3dba-ae21-4268-ac8b-342aaa609554 | 2026-05-18 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | c4a3018a-3cd8-4e07-a840-099ceae01c91 | 2026-05-15 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 51b66893-f7d6-8f9d-e063-6294a90a8e9b | 2026-05-13 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Lupin Pharmaceuticals, Inc. | df661166-325d-4071-9bc1-f7bf992996d2 | 2026-05-11 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | ASCLEMED USA INC. | a3c57d82-511c-4c7d-84ff-f791f931f576 | 2026-05-07 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 513f422f-1637-5f41-e063-6294a90ab548 | 2026-05-07 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | 65a76fcb-31a8-4c5a-9ffe-5393fc4dac34 | 2026-05-06 | Warnings, Adverse reactions | LEVETIRACETAM |
| levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ba18ead0-69d7-453a-badc-cd6ad376d18e | 2026-05-06 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 5037a86a-21f2-d793-e063-6394a90a2cb5 | 2026-04-24 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | Bionpharma Inc. | 1d75b15e-881c-a00f-e063-6394a90a4138 | 2026-04-17 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Aryeh Pharma corp | 4f8ffd81-f814-f288-e063-6394a90a5eb5 | 2026-04-16 | Warnings, Adverse reactions | LEVETIRACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.